Literature DB >> 15587916

Stabilization of proteins in dry powder formulations using supercritical fluid technology.

Natasa Jovanović1, Andréanne Bouchard, Gerard W Hofland, Geert-Jan Witkamp, Daan J A Crommelin, Wim Jiskoot.   

Abstract

Therapeutic proteins have become essential in the treatment of many diseases. Their formulation in dry form is often required to improve their stability. Traditional freeze-drying or spray-drying processes are often harmful to labile proteins and could be replaced by supercritical fluid (SCF) drying to produce particles with defined physicochemical characteristics in a mild single step. A survey of the current SCF drying processes for proteins is presented to give insight into the effect of SCF drying on protein stability and to identify issues that need further investigation. Methods used for drying aqueous and organic protein solutions are described. In particular, effects of process and formulation parameters on particle formation and protein stability are discussed. Although SCF methodology for drying proteins is still in its infancy, it can provide a serious alternative to existing drying methods for stabilizing proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15587916     DOI: 10.1023/b:pham.0000048185.09483.e7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Bacterial inactivation by using near- and supercritical carbon dioxide.

Authors:  A K Dillow; F Dehghani; J S Hrkach; N R Foster; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 2.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

3.  Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system.

Authors:  Rana T Bustami; Hak-Kim Chan; Theresa Sweeney; Fariba Dehghani; Neil R Foster
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

4.  Long-term and high-temperature storage of supercritically-processed microparticulate protein powders.

Authors:  M A Winters; P G Debenedetti; J Carey; H G Sparks; S U Sane; T M Przybycien
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

5.  Supercritical fluid precipitation of recombinant human immunoglobulin from aqueous solutions.

Authors:  D P Nesta; J S Elliott; J P Warr
Journal:  Biotechnol Bioeng       Date:  2000-02-20       Impact factor: 4.530

6.  CO2 and fluorinated solvent-based technologies for protein microparticle precipitation from aqueous solutions.

Authors:  Marazban Sarkari; Inaas Darrat; Barbara L Knutson
Journal:  Biotechnol Prog       Date:  2003 Mar-Apr

7.  Precipitation of proteins in supercritical carbon dioxide.

Authors:  M A Winters; B L Knutson; P G Debenedetti; H G Sparks; T M Przybycien; C L Stevenson; S J Prestrelski
Journal:  J Pharm Sci       Date:  1996-06       Impact factor: 3.534

8.  The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody.

Authors:  J D Andya; Y F Maa; H R Costantino; P A Nguyen; N Dasovich; T D Sweeney; C C Hsu; S J Shire
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

9.  Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.

Authors:  N Elvassore; A Bertucco; P Caliceti
Journal:  J Pharm Sci       Date:  2001-10       Impact factor: 3.534

10.  Micronization of insulin from halogenated alcohol solution using supercritical carbon dioxide as an antisolvent.

Authors:  William K Snavely; Bala Subramaniam; Roger A Rajewski; Michael R Defelippis
Journal:  J Pharm Sci       Date:  2002-09       Impact factor: 3.534

View more
  17 in total

1.  Near-infrared imaging for studying homogeneity of protein-sugar mixtures.

Authors:  Natasa Jovanović; Ad Gerich; Andréanne Bouchard; Wim Jiskoot
Journal:  Pharm Res       Date:  2006-08-12       Impact factor: 4.200

2.  Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.

Authors:  Ahmad M Abdul-Fattah; Vu Truong-Le; Luisa Yee; Emilie Pan; Yi Ao; Devendra S Kalonia; Michael J Pikal
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

3.  Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Punit Bhatnagar; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

4.  Histological Quantification of Gene Silencing by Intratracheal Administration of Dry Powdered Small-Interfering RNA/Chitosan Complexes in the Murine Lung.

Authors:  Daisuke Ihara; Noboru Hattori; Yasushi Horimasu; Takeshi Masuda; Taku Nakashima; Tadashi Senoo; Hiroshi Iwamoto; Kazunori Fujitaka; Hirokazu Okamoto; Nobuoki Kohno
Journal:  Pharm Res       Date:  2015-07-03       Impact factor: 4.200

Review 5.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

6.  Preparation of polymeric submicron particle-containing microparticles using a 4-fluid nozzle spray drier.

Authors:  Tetsuya Ozeki; Shuji Beppu; Takuto Mizoe; Yuuki Takashima; Hiroshi Yuasa; Hiroaki Okada
Journal:  Pharm Res       Date:  2006-11-08       Impact factor: 4.200

7.  Self-built supercritical CO2 anti-solvent unit design, construction and operation using carbamazepine.

Authors:  Dan Meng; James Falconer; Karen Krauel-Goellner; John J J J Chen; Mohammed Farid; Raid G Alany
Journal:  AAPS PharmSciTech       Date:  2008-08-09       Impact factor: 3.246

8.  Influence of stabilizers on the physicochemical characteristics of inhaled insulin powders produced by supercritical antisolvent process.

Authors:  Yong Ho Kim; Constantinos Sioutas; Katherine S Shing
Journal:  Pharm Res       Date:  2008-09-04       Impact factor: 4.200

Review 9.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 10.  Delivery of therapeutic proteins.

Authors:  Dipak S Pisal; Matthew P Kosloski; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2010-06       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.